Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3024-9. doi: 10.1073/pnas.1506012113. Epub 2016 Feb 22.

Abstract

A major hypothesis in addiction research is that alcohol induces neuroadaptations in the mesolimbic dopamine (DA) system and that these neuroadaptations represent a key neurochemical event in compulsive drug use and relapse. Whether these neuroadaptations lead to a hypo- or hyperdopaminergic state during abstinence is a long-standing, unresolved debate among addiction researchers. The answer is of critical importance for understanding the neurobiological mechanism of addictive behavior. Here we set out to study systematically the neuroadaptive changes in the DA system during the addiction cycle in alcohol-dependent patients and rats. In postmortem brain samples from human alcoholics we found a strong down-regulation of the D1 receptor- and DA transporter (DAT)-binding sites, but D2-like receptor binding was unaffected. To gain insight into the time course of these neuroadaptations, we compared the human data with that from alcohol-dependent rats at several time points during abstinence. We found a dynamic regulation of D1 and DAT during 3 wk of abstinence. After the third week the rat data mirrored our human data. This time point was characterized by elevated extracellular DA levels, lack of synaptic response to D1 stimulation, and augmented motor activity. Further functional evidence is given by a genetic rat model for hyperdopaminergia that resembles a phenocopy of alcohol-dependent rats during protracted abstinence. In summary, we provide a new dynamic model of abstinence-related changes in the striatal DA system; in this model a hyperdopaminergic state during protracted abstinence is associated with vulnerability for relapse.

Keywords: alcoholism; dopamine release; in silico analysis; postmortem brain tissue; translational studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / analysis
  • Adult
  • Aged
  • Alcohol Abstinence*
  • Alcoholism / metabolism*
  • Animals
  • Benzazepines / pharmacology
  • Brain Chemistry
  • Disease Models, Animal
  • Dopamine / physiology*
  • Dopamine Plasma Membrane Transport Proteins / genetics
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Ethanol / adverse effects*
  • Ethanol / toxicity
  • Excitatory Postsynaptic Potentials / drug effects
  • Female
  • Gene Expression Regulation
  • Homovanillic Acid / analysis
  • Humans
  • Male
  • Middle Aged
  • Motor Activity / drug effects
  • Nucleus Accumbens / metabolism
  • Rats
  • Rats, Transgenic
  • Rats, Wistar
  • Receptors, Dopamine D1 / genetics
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / genetics
  • Receptors, Dopamine D2 / metabolism
  • Recurrence
  • Substance Withdrawal Syndrome / metabolism*
  • Transcription, Genetic

Substances

  • Benzazepines
  • DRD2 protein, human
  • Dopamine Plasma Membrane Transport Proteins
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • 3,4-Dihydroxyphenylacetic Acid
  • Ethanol
  • SK&F 81297
  • Dopamine
  • Homovanillic Acid